Astrana Health (ASTH) Projected to Post Quarterly Earnings on Monday

Astrana Health (NASDAQ:ASTH) is expected to be issuing its Q4 2025 results before the market opens on Monday, March 2nd. Analysts expect the company to announce earnings of $0.15 per share and revenue of $930.4570 million for the quarter. Individuals can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Monday, March 2, 2026 at 8:30 AM ET.

Astrana Health Trading Up 0.5%

NASDAQ:ASTH opened at $19.86 on Monday. The firm has a market cap of $1.12 billion, a PE ratio of 104.53, a price-to-earnings-growth ratio of 0.59 and a beta of 0.91. The stock has a fifty day moving average price of $23.80 and a 200 day moving average price of $26.56. Astrana Health has a 12-month low of $18.08 and a 12-month high of $38.09. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.27.

Wall Street Analyst Weigh In

ASTH has been the topic of a number of analyst reports. Barclays reduced their price target on Astrana Health from $36.00 to $26.00 and set an “equal weight” rating on the stock in a research report on Monday, November 24th. BTIG Research reduced their target price on shares of Astrana Health from $45.00 to $40.00 and set a “buy” rating on the stock in a report on Monday, February 2nd. Zacks Research cut shares of Astrana Health from a “hold” rating to a “strong sell” rating in a report on Tuesday, February 10th. Needham & Company LLC began coverage on shares of Astrana Health in a research report on Friday, December 12th. They issued a “buy” rating and a $28.00 price objective on the stock. Finally, Jefferies Financial Group reaffirmed a “buy” rating on shares of Astrana Health in a research report on Tuesday, November 25th. Seven analysts have rated the stock with a Buy rating, one has issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $38.88.

Institutional Trading of Astrana Health

Institutional investors have recently modified their holdings of the stock. State Street Corp grew its position in shares of Astrana Health by 6.2% in the 4th quarter. State Street Corp now owns 1,675,516 shares of the company’s stock valued at $41,570,000 after buying an additional 98,064 shares during the last quarter. Geode Capital Management LLC boosted its stake in Astrana Health by 1.2% in the fourth quarter. Geode Capital Management LLC now owns 1,028,168 shares of the company’s stock valued at $25,513,000 after acquiring an additional 12,212 shares in the last quarter. Wellington Management Group LLP grew its holdings in shares of Astrana Health by 418.3% during the fourth quarter. Wellington Management Group LLP now owns 738,853 shares of the company’s stock worth $18,331,000 after purchasing an additional 596,293 shares during the last quarter. Jacobs Levy Equity Management Inc. increased its position in shares of Astrana Health by 19.2% during the third quarter. Jacobs Levy Equity Management Inc. now owns 500,527 shares of the company’s stock worth $14,190,000 after purchasing an additional 80,465 shares in the last quarter. Finally, Ameriprise Financial Inc. lifted its holdings in shares of Astrana Health by 231.0% in the 3rd quarter. Ameriprise Financial Inc. now owns 442,314 shares of the company’s stock valued at $12,540,000 after purchasing an additional 308,665 shares during the last quarter. Hedge funds and other institutional investors own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.